190 related articles for article (PubMed ID: 32229502)
1. Aquaporin-9, Mediated by IGF2, Suppresses Liver Cancer Stem Cell Properties via Augmenting ROS/β-Catenin/FOXO3a Signaling.
Zheng X; Li C; Yu K; Shi S; Chen H; Qian Y; Mei Z
Mol Cancer Res; 2020 Jul; 18(7):992-1003. PubMed ID: 32229502
[TBL] [Abstract][Full Text] [Related]
2. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
[TBL] [Abstract][Full Text] [Related]
3. Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via Wnt/β-catenin pathway.
Liao S; Chen H; Liu M; Gan L; Li C; Zhang W; Lv L; Mei Z
Aging (Albany NY); 2020 Jan; 12(2):1527-1544. PubMed ID: 31969493
[TBL] [Abstract][Full Text] [Related]
4. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
[TBL] [Abstract][Full Text] [Related]
5. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
Chen L; Wu M; Ji C; Yuan M; Liu C; Yin Q
IUBMB Life; 2020 Feb; 72(2):285-295. PubMed ID: 31580537
[TBL] [Abstract][Full Text] [Related]
6. Anticancer Effect of Polyphyllin I in Suppressing Stem Cell-Like Properties of Hepatocellular Carcinoma via the AKT/GSK-3
Liao M; Du H; Wang B; Huang J; Huang D; Tong G
Oxid Med Cell Longev; 2022; 2022():4031008. PubMed ID: 36317061
[TBL] [Abstract][Full Text] [Related]
7. Aquaporin 9 is down-regulated in hepatocellular carcinoma and its over-expression suppresses hepatoma cell invasion through inhibiting epithelial-to-mesenchymal transition.
Zhang WG; Li CF; Liu M; Chen XF; Shuai K; Kong X; Lv L; Mei ZC
Cancer Lett; 2016 Aug; 378(2):111-9. PubMed ID: 27216981
[TBL] [Abstract][Full Text] [Related]
8. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
9. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
Liu F; Wu X; Jiang X; Qian Y; Gao J
J Exp Clin Cancer Res; 2018 Jun; 37(1):122. PubMed ID: 29940988
[TBL] [Abstract][Full Text] [Related]
10. PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma.
Li M; Mu XD; Song JR; Zhai PT; Cheng Y; Le Y; Li ZB
Cell Cycle; 2021 May; 20(10):1010-1020. PubMed ID: 33970778
[TBL] [Abstract][Full Text] [Related]
11. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.
Sun L; Wang Y; Wang L; Yao B; Chen T; Li Q; Liu Z; Liu R; Niu Y; Song T; Liu Q; Tu K
J Exp Clin Cancer Res; 2019 Apr; 38(1):170. PubMed ID: 30999932
[TBL] [Abstract][Full Text] [Related]
12. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo.
Peng R; Zhao GX; Li J; Zhang Y; Shen XZ; Wang JY; Sun JY
World J Gastroenterol; 2016 Mar; 22(12):3341-54. PubMed ID: 27022216
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
Ma YS; Lv ZW; Yu F; Chang ZY; Cong XL; Zhong XM; Lu GX; Zhu J; Fu D
J Exp Clin Cancer Res; 2018 Oct; 37(1):252. PubMed ID: 30326936
[TBL] [Abstract][Full Text] [Related]
14. AQP9 suppresses hepatocellular carcinoma cell invasion through inhibition of hypoxia-inducible factor 1α expression under hypoxia.
Qian Y; Liu F; Zhang W; Zheng X; Liao S; Lv L; Mei Z
J Gastroenterol Hepatol; 2020 Nov; 35(11):1990-1997. PubMed ID: 32115773
[TBL] [Abstract][Full Text] [Related]
15. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling.
Ren KQ; Cao XZ; Liu ZH; Guo H; Quan MF; Liu F; Jiang L; Xiang HL; Deng XY; Cao JG
Int J Oncol; 2013 Nov; 43(5):1719-29. PubMed ID: 23970349
[TBL] [Abstract][Full Text] [Related]
16. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
Liu M; Bamodu OA; Kuo KT; Lee WH; Lin YK; Wu ATH; M H; Tzeng YM; Yeh CT; Tsai JT
Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038
[TBL] [Abstract][Full Text] [Related]
18. Salinomycin Suppresses Tumorigenicity of Liver Cancer Stem Cells and Wnt/Beta-catenin Signaling.
Liu Q; Sun J; Luo Q; Ju Y; Song G
Curr Stem Cell Res Ther; 2021; 16(5):630-637. PubMed ID: 31971116
[TBL] [Abstract][Full Text] [Related]
19. Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression.
Deng Y; Li M; Zhuo M; Guo P; Chen Q; Mo P; Li W; Yu C
J Biol Chem; 2021; 296():100121. PubMed ID: 33434575
[TBL] [Abstract][Full Text] [Related]
20. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM
Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E
Cells; 2020 May; 9(5):. PubMed ID: 32408542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
